Fall Obesity Summit 2022

Utilizing the Four Pillars of Obesity and Beyond

Anaheim, CA

Date: October 14-16, 2022
Accreditation: 17.5 CME/CE
Schedule: 
Friday, Oct. 14 – 8:00 AM-4:45 PM PST*
Saturday, Oct. 15 – 8:30 AM-5:15 PM PST*
Sunday, Oct. 16 – 7:30 AM-12:30 PM PST*

*times are subject to change

The Fall Obesity Summit will expand your skills used to treat patients with obesity. Session content will explore obesity evaluation and treatment in each of the 4 pillars – pharmacotherapy, nutrition, physical activity, and behavioral modification. The program will include late breaking research on phenotypic-guided lifestyle interventions, emerging pharmacotherapy for obesity treatment, utilizing motivational interviewing, special populations, and much, much more. 

Sessions during this track will focus on: 

  • Clinical applications for anti-obesity medications 
  • Treating obesity in special populations and how to appropriately modify your care 
  • Physiologic implications of nutrition interventions and creating personalized meal plans 
  • Exploring the benefits and limitations of physical activity in obesity treatment 

Pediatric, Adolescent and Young Adult Track

The Pediatric, Adolescent and Young Adult Track is designed to provide clinicians with updated information regarding utilizing advanced tools of weight management, such as anti-obesity medications and metabolic-bariatric surgery, for children, adolescents and young adults with obesity. Clinicians will walk away with a better understanding of how to treat obesity in special pediatric populations, including those with genetic or syndromic obesity, intellectual disabilities, and behavioral issues such as autism spectrum disorder. Clinicians will also learn how to address the unique obesity-related medical and behavioral issues of adolescents transitioning into young adulthood and gender diverse youth. 

Register Now

Schedule on Friday, October 14, 2022

All times displayed in Pacific Time (PT)

  • 6:15-7:00 AM - Experts on the Move (optional CME)

    6:15-7:00 AM - Experts on the Move (optional CME)

  • 7:00-8:00 AM - Exhibit Hall Breakfast

    7:00-8:00 AM - Exhibit Hall Breakfast

  • 8:00-8:15 AM - Presidential Address

    8:00-8:15 AM - Presidential Address

    Speaker

    Ethan Lazarus, MD

  • 8:15-9:15 AM - Opening General Session | Connecting Across Generations

    8:15-9:15 AM - Opening General Session | Connecting Across Generations

    Speaker

    Lisa Walden

    Description

    Each generation ushers in a unique perspective on how we work and live. Whether it’s embracing daily usage of emojis, asking for efficiency in meetings, establishing clarity through hierarchy, or demanding diverse representation, every generational cohort leaves a distinct mark. These differences in perspective are wonderful and enriching, but can also cause frustration and disconnection when not properly understood. 
     
    In this presentation, Lisa brings some clarity to the generational conversation, providing an extra lens for you to better connect with those you interact with every day. She’ll break down the heart of generational theory, bust some common stereotypes, and generate awareness for why each generation behaves the way they do. Armed with the power of generational understanding, you can venture into the work world work with the tools you need to improve connection and build stronger relationships with colleagues and patients alike. 

    Learning Objectives

    1. Decrypting every generation’s formative years, and how those experiences inform distinct generational identities 
    2. Identify the potential areas for disconnect across generations, and how to overcome those barriers and build stronger relationships 
    3. Explore how the newest generation, Gen Z, will shake up how we work, communicate, and connect 
  • 9:30-10:30 AM - How to Manage Weight Regain after Bariatric Surgery

    9:30-10:30 AM - How to Manage Weight Regain after Bariatric Surgery

    Speaker

    Alicia Shelly, MD, FACP

    Description

    This session will discuss the prevalence and etiologies of weight regain after bariatric surgery. It will also discuss current available treatments for managing Weight Regain after bariatric surgery.  This interactive session will utilize case-based learning to explore best practices for treatment of weight regain after bariatric surgery.

    Learning Objectives

    1. Define weight regain and discuss the prevalence of weight regain after bariatric surgery. 
    2. Manage patients who suffer with weight regain after bariatric surgery. 
    3. Describe the causes of weight regain after bariatric surgery. 
  • 10:30-11:30 AM - Making the Switch: Transitioning from Weight-promoting Medicines

    10:30-11:30 AM - Making the Switch: Transitioning from Weight-promoting Medicines

    Speakers

    Elizabeth Mills, PharmD, BCACP, CDCES

    Katie Trotta, PharmD, BCACP

    Description

    A core component of obesity treatment includes recognition of weight promoting medications and their alternatives.  Transitioning off of weight promoting medications onto weight friendly alternative is another challenge. This session will identify commonly used medications that are known to promote weight gain and the benefits of their more favorable substitutes. The program will explore key considerations for safe transition off of weight positive medications along with strategies to prevent unintended complications from medication withdrawal.

    Learning Objectives

    1. Identify commonly use medications that promote weight gain 
    2. List suitable alternatives to weight promoting medications 
    3. Utilize strategies for the safe transition off of weight promoting medications and on to weight favorable alternatives 
  • 12:45-1:45 PM - On the Horizon: The Future of Anti-Obesity Medications

    12:45-1:45 PM - On the Horizon: The Future of Anti-Obesity Medications

    Speaker

    Donna Ryan, MD, MABOM, FTOS

    Description

    Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning. There is a rich pipeline of future anti-obesity medications (AOM) that will give provides excellent options for both the treatment of obesity and of the obesity-related diseases. This session will start with reviewing some of the common pathophysiologic pathways that current and future AOM’s target then discuss emerging and future prospects of pharmacotherapy for the treatment of obesity.

    Learning Objectives

    1. Identify pathophysiologic pathways targeted to treat obesity 
    2. Discuss emerging therapies for the medical treatment of obesity 
    3. Describe some novel obesity treatments under investigation 
    4. Discuss the role cardiovascular outcomes may play in the evaluation of AOM’s 
  • 1:45-2:00 PM - Pharmacology Q&A

    1:45-2:00 PM - Pharmacology Q&A

    Speakers

    Katie Trotta, PharmD, BCACP

    Elizabeth Mills, PharmD, BCACP, CDCES

    Donna Ryan, MD, MABOM, FTOS

    Learning Objectives

    1. Discuss key takeaways from the pharmacology lectures 
    2. Ask specific questions about managing obesity with the use of pharmacology in a Q&A panel with faculty experts. 
  • 2:45-3:45 PM - Weight a Minute: Considerations for Physical Activity Being Effective for Weight Loss and Maintenance

    2:45-3:45 PM - Weight a Minute: Considerations for Physical Activity Being Effective for Weight Loss and Maintenance

    Speaker

    John Jakicic, PhD

    Description

    Physical activity is considered an important component of obesity treatment; however, the effect of physical activity on weight can be variable. Moreover, the dose, intensity, and mode of physical activity may contribute to the weight loss response. This session will explore these factors related to the effects of physical activity on weight loss and with weight maintenance.   

    Learning Objectives

    1. Describe the effects of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity.
    2. Describe the effects of different volumes and intensities of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity.  
    3. Describe the effects of different modes of physical activity on weight loss and weight loss maintenance in adults with overweight or obesity. 
  • 3:45-4:30 PM - Physical Activity Case Studies

    3:45-4:30 PM - Physical Activity Case Studies

    Speakers

    John Jakicic, PhD

    Carl Knopke MD, FOMA, FAAFP

    Karli Burridge PA-C, MMS, FOMA

    Description

    Knowledge is good, skills are better. This session will focus on applying physical activity programs in the treatment of obesity. The cases will involve developing an activity plan with a patient, tracking progress, and overcoming challenges to maintaining an activity plan.

    Learning Objectives

    1. Develop a patient-centered activity plan
    2. Utilize tools to track physical activity progress and outcomes 
    3. Analyze and strategize ways to help overcome activity limitations 
  • 4:30-4:45 PM - Physical Activity Q&A

    4:30-4:45 PM - Physical Activity Q&A

    Speakers

    John Jakicic, PhD

    Carl Knopke MD, FOMA, FAAFP

    Karli Burridge PA-C, MMS, FOMA

    Learning Objectives

    1. Discuss key takeaways from the physical activity lectures
    2. Ask specific questions about managing obesity with the use of physical activity in a Q&A panel with faculty experts. 
  • 7:00-10:00 PM - Member Appreciation Event*
    7:00-10:00 PM - Member Appreciation Event*

    7:00-10:00 PM - Member Appreciation Event*

    Friday, Oct. 14 | 7:00 – 10:00pm | The Fifth Rooftop

    Cost: $25 for Members, $50 per Member Guest

    OMA members get the chance to celebrate with fellow obesity medicine specialists at The Fifth Rooftop in Anaheim. Come relax at the 5,000 square foot open air rooftop. Help us recognize OMA’s leaders’ accomplishments and incoming board members. Join us for delicious food, craft cocktails, stunning sunset views, firepits, music, and more. Also, experience Disney fireworks after dark!

    *Member event only. Limited capacity. Registration required as add-on to conference registration.

Schedule on Saturday, October 15, 2022

All times displayed in Pacific Time (PT)

  • 7:00-7:30 AM - Exhibit Hall Breakfast

    7:00-7:30 AM - Exhibit Hall Breakfast

  • 7:30-8:15 AM - Breakfast with the Experts (Optional CME)

    7:30-8:15 AM - Breakfast with the Experts (Optional CME)

    Description

    This is a great opportunity to explore a topic of interest with an obesity medicine specialist with expertise in the field. These are small-group sessions that allow for engaging conversation. Choose a table with a topic that interests you and spend breakfast discussing that topic with an expert and a few other colleagues. 

    *This event is worth an optional 0.75 CME/CE credits. Attendance is not required to earn the full 17.5 CME/CE credits for the Fall Obesity Summit. 

  • 8:30-9:30 AM - Industry Keynote: Robert Lustig, MD, MSL

    8:30-9:30 AM - Industry Keynote: Robert Lustig, MD, MSL

    Speaker

    Robert Lustig, MD, MSL

    Learning Objectives

    1. Recognize the importance of liver fat in chronic disease
    2. Describe the role of mitochondria in liver fat  
    3. Discuss the role of fructose in mitochondrial dysfunction  
    4. Utilize lifestyle strategies to protect liver function 
  • 10:00-11:00 AM - Difficult Conversations: Bringing Motivational Interviewing to Life

    10:00-11:00 AM - Difficult Conversations: Bringing Motivational Interviewing to Life

    Speakers

    Sandra Christensen MSN, ARNP, FNP-BC, FOMA

    Lori Wenz, NP-C, BC-ADM

    Description

    Obesity medicine clinicians routinely have challenging conversations with patients. Many patients have emotionally charged histories about their weight and health. Previous encounters with biased clinicians influence a patient’s willingness to trust the clinician and engage in treatment. 
    In this presentation, the presenters will demonstrate real-life clinical conversations that utilize a coaching mindset and incorporate the concepts of Motivational Interviewing and the 5 As of obesity counseling. We will go beyond theories and demonstrate examples of what works. Because telling a patient what to do or how to feel rarely works, clinicians will learn how to structure the conversation in a manner that establishes and maintains trust in the therapeutic relationship, elicits the patient’s motivation to change, and leads to improved health behaviors. 

    Learning Objectives

    1. Recognize the importance of establishing and maintaining trust in the therapeutic relationship
    2. Describe the theoretical frameworks of Motivational Interviewing, the 5 As of obesity counseling, and health coaching
    3. Integrate the concepts of Motivational Interviewing, the 5 As of obesity counseling, and health coaching into common, real-life clinical conversations 
  • 11:00 AM-12:00 PM - Shared Decision Making on Eating Plan Selections

    11:00 AM-12:00 PM - Shared Decision Making on Eating Plan Selections

    Speaker

    Angela Golden, DNP, FNP-C, FAANP

    Description

    Many practices do not have nutritional professionals to assist their patients make eating plan selections. Providers are called upon to help the patients with this important pillar of care. This presentation will review the current evidence for nutrition treatment in obesity including meal patterns and eating plans. Using case studies the presentation will provide examples of shared decision-making for goal setting to help patients move to using food as part of their successful obesity treatment plan.

    Learning Objectives

    1. Evaluate current evidence for diets and meal patterns for the treatment of obesity
    2. List the advantages for each eating plan based on patient's lifestyle and ORCs 
    3. Analyze food logs to provide guidance to a patient 
  • 12:00-12:15 PM - Behavior Q&A

    12:00-12:15 PM - Behavior Q&A

    Speakers

    Sandra Christensen, MSN, ARNP, FNP-BC, FOMA

    Lori Wenz, NP-C, BC-ADM

    Angela Golden, DNP, FNP-C, FAANP

    Learning Objectives

    1. Discuss key takeaways from the behavior lectures
    2. Ask specific questions about managing obesity with behavior modification in a Q&A panel with faculty experts. 
  • 12:15-1:30PM - Lunch in the Exhibit Hall

    12:15-1:30PM - Lunch in the Exhibit Hall

  • 1:30PM - Trail Map and Membership Raffle Drawings

    1:30PM - Trail Map and Membership Raffle Drawings

  • 1:45-2:45 PM - Phenotype-Guided Lifestyle Intervention for Obesity Management

    1:45-2:45 PM - Phenotype-Guided Lifestyle Intervention for Obesity Management

    Speaker

    Andres Acosta, MD

    Description

    Obesity is a chronic, relapsing, and multifactorial disease with significant individual variability in response to therapeutic interventions. This session will discuss the heterogeneity of human obesity and identifying predictors of response to weight loss interventions. Specifically, we identified four potential pathophysiologic and behavioral obesity phenotypes: abnormal satiation, abnormal postprandial satiety, abnormal emotional eating, and abnormal resting energy expenditure. We hypothesize that obesity-related phenotypes may predict weight loss to an Individualized Lifestyle intervention based on a tailored Mayo Clinic Diet program. This session will introduce preliminary data using a tailored Mayo Clinic Diet program and phenotypic guided lifestyle interventions to enhance obesity treatment outcomes.

    Learning Objectives

    1. Describe the heterogeneity of obesity
    2. Identify proposed obesity phenotype classifications 
    3. Discuss preliminary outcomes of a phenotype-guided lifestyle intervention 
  • 2:45-3:45 PM - The Carbohydrate-Insulin Model of Obesity: The Evidence For and Against

    2:45-3:45 PM - The Carbohydrate-Insulin Model of Obesity: The Evidence For and Against

    Speakers

    Eric Westman, MD, MHS, MFOMA

    Justin Tondt, MD

    Description

    This session will explore the current scientific evidence both for and against the CIM to prepare participants to critically evaluate this and other models of obesity.

    Learning Objectives

    1. Summarize the current evidence for the carbohydrate-insulin model of obesity.
    2. Summarize the current evidence against the carbohydrate-insulin model of obesity. 
    3. Compare and contrast the carbohydrate-insulin model of obesity to other models of obesity. 
  • 4:00-5:00 PM - Plan(t)s for Weight Loss - How to Incorporate Plant-Based Diets into Your Practice

    4:00-5:00 PM - Plan(t)s for Weight Loss - How to Incorporate Plant-Based Diets into Your Practice

    Speaker

    Jennifer Ng, MD, Dipl ABOM

    Description

    This session will review the benefits of plant-based diets in obesity management and how to incorporate plant-based diets into your practice.  During the presentation, Dr. Ng will go over the evidence supporting plant-based diets in obesity management as well as important nutritional aspects of plant-based diets to counsel your patient on and how to start/overcome barriers for your patients on plant-based diets.  

    Learning Objectives

    1. Understand how plant-based diets can benefit obesity management
    2. Discuss how to get started integrating a plant-based diet into medical practice 
    3. Learn how to work with patients to motivate them to utilize a plant-based diet to improve the quality of their nutrition 
  • 5:00-5:15 PM - Nutrition Q&A

    5:00-5:15 PM - Nutrition Q&A

    Speakers

    Eric Westman, MD, MHS, MFOMA

    Justin Tondt, MD

    Andres Acosta, MD, PhD

    Learning Objectives

    1. Discuss key takeaways from the nutrition lectures
    2. Ask specific questions about managing obesity with the use of nutrition in a Q&A panel with faculty experts. 
  • 6:15 PM - Dine-arounds (Optional)

    6:15 PM - Dine-arounds (Optional)

    Need dinner plans? Sign up to attend a vendor sponsored dine-around on Saturday night! Dinner reservations at the best restaurants near the hotel have been made, so you can spend a stress-free evening out getting to know your colleagues and learning from our vendors. (Dinner costs are covered by the vendor. Advance sign-up required in the mobile app.)

Schedule on Sunday, October 16, 2022

All times displayed in Pacific Time (PT)

  • 6:00-7:00 AM - Fun Run

    6:00-7:00 AM - Fun Run

    Get your blood pumping during an early morning fun run led by one of our physical activity experts. Take in the sights as you run or jog around the city with a group of fellow attendees. 

  • 7:30-8:30 AM - Patient Perspective | Behind the Data: The Lived Experience of Childhood and Adolescent Obesity and Finding Common Ground

    7:30-8:30 AM - Patient Perspective | Behind the Data: The Lived Experience of Childhood and Adolescent Obesity and Finding Common Ground

    Speaker

    Faith Newsome, BA

    Description

    In this session, Faith Newsome will describe her experiences living with obesity, which eventually culminated in her decision to undergo bariatric surgery at 16. Throughout the session, Newsome will bring to life the data and statistics that those working in obesity know well by telling personal stories. Newsome will also identify opportunities for patient-centered care, and for patients to participate in the research process. 

    Learning Objectives

    1. Describe the lived experiences of pediatric patients living with obesity
    2. Identify opportunities to practice-patient centered care 
    3. Identify opportunities for collaboration with patients in the research process 
  • 8:30-9:30 AM - CBD for Obesity? Our Patients are Asking! A Review of the Current Science

    8:30-9:30 AM - CBD for Obesity? Our Patients are Asking! A Review of the Current Science

    Speaker

    Jeff Sicat, MD, FACE, FOMA

    Description

    Our patients frequently ask if they should take CBD to assist with weight loss. This presentation will review the role of the endocannabinoid system (ECS) in weight management and discuss the current science and data regarding the impact of CBD and CBD derivatives on obesity, insulin resistance, and metabolic disease.

    Learning Objectives

    1. Explain the physiology of the endocannabinoid system and how it affects metabolic features
    2. Describe the scientific studies of CBD and derivatives impacting obesity and the metabolic system 
    3. Formulate thoughts on whether CBD may be an intervention for metabolic disease 
  • 9:45-10:30 AM - OMA Clinical Practice Statement Updates: With a Focus on Obesity, Cancer, and Fatty Liver

    9:45-10:30 AM - OMA Clinical Practice Statement Updates: With a Focus on Obesity, Cancer, and Fatty Liver

    Speaker

    Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

    Description

    The Obesity Medicine Association (OMA) is a science leader regarding clinical obesity medicine. OMA has published several Clinical Practice Statements via its journal - Obesity Pillars. The intent of these CPS is to help clinicians manage patients with obesity. This session will provide a brief overview of some of the more recent OMA Clinical Practice Statements.

    Learning Objectives

    1. Describe the basic concepts regarding Clinical Practice Statements (CPS) published by the Obesity Medicine Association OMA
    2. Identify contents location of OMA CPS. 
    3. Utilize the resources provided by CPS and the Obesity Pillars 
  • 10:30-11:30 AM - Gender Differences in Obesity Treatment

    10:30-11:30 AM - Gender Differences in Obesity Treatment

    Speaker

    Daniela Hurtado Andrade, MD, PhD

    Description

    The treatment approaches to obesity care often give little regard to gender specific needs in weight management.  Nutritional, behavioral, and physical activity treatments vary widely between gender across the lifespan. This presentation will highlight key differences in the pathophysiology of obesity between men and women and how those difference impact obesity treatment. 

    Learning Objectives

    1. Identify the pathophysiologic differences of obesity in men and women
    2. Consider gender specific metabolic and psychologic needs across the lifespan 
    3. Describe the limitations of obesity research in men and women 
    4. Utilize gender specific therapies for obesity 
  • 11:30 AM-12:30 PM - Emerging from the Shadows – Recognizing and Treating Lipedema

    11:30 AM-12:30 PM - Emerging from the Shadows – Recognizing and Treating Lipedema

    Speaker

    Karen Herbst, MD, PhD

    Description

    One of the limitations of BMI is that it fails to account for either body composition or body fat distribution. While patients with lipedema may have a BMI >30kg/m2, their condition is very different from most obesity associated with positive energy balance. Accumulation of fibroadipose tissue in the lower body and arms has distinct pathologic features as well as resistance to conventional therapies. This session will examine how lipedema is different from most forms of obesity, how it is diagnosed, and the unique treatment strategies used to combat this challenging condition.

    Learning Objectives

    1. Define lipedema and distinguish it from other adiposity-related disorders 
    2. Discuss the Standards of Care for Lipedema in the US 
    3. Describe the role of supplements, nutrition, manual therapy, and surgery in lipedema treatment 
    4. Utilize effective treatment strategies for patients with lipedema 

Register Now


Pediatric, Adolescent and Young Adult Track

See below for Saturday’s schedule for the optional Pediatric, Adolescent and Young Adult track.

  • 10:00-11:00 AM - Metabolic-Bariatric Surgery Roundtable

    10:00-11:00 AM - Metabolic-Bariatric Surgery Roundtable

    Speakers

    Janey Pratt, MD, FACS, FASMBS

    Allen Browne, MD, FACS, FAAP

    Melissa Santos, PhD

    Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM

    Description

    This roundtable discussion covers metabolic bariatric surgery in children and adolescents based on the 2018 ASMBS pediatric metabolic and bariatric surgery guidelines.

    Learning Objectives

    1. Discuss the criteria, benefits, and risks for MBS in children and adolescents 
    2. Discuss changes in the criteria for MBS between the previous guidelines in 2012 and the 2018 guidelines 
    3. Review MBS in the context of a child or adolescent with high risk social issues 
    4. Review decision making for children and adolescents who are being considered for MBS 
  • 11:00 AM-12:00 PM - Use of Advanced Weight Management Tools in Special Populations

    11:00 AM-12:00 PM - Use of Advanced Weight Management Tools in Special Populations

    Speakers

    Evan Nadler, MD, MBA

    Brooke Sweeney MD, FAAP, DABOM

    Description

    This session will be an overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.

    Learning Objectives

    1. Discuss the assessment of children with special needs and obesity 
    2. Review advanced behavioral tools for children with obesity and special healthcare needs 
    3. Discover how to use anti-obesity pharmacotherapy in a special needs population and children with medical complexity 
    4. Review surgical guidelines and outcomes in children with obesity, and in children with special needs and medical complexity 
  • 12:00-12:15 PM - Pediatric Q&A

    12:00-12:15 PM - Pediatric Q&A

    Speakers

    Evan Nadler, MD, MBA

    Brooke Sweeney, MD, FAAP, DABOM 

    Learning Objectives

    1. Discuss key takeaways from the Advanced Weight Management Tools in Special Populations lecture 
    2. Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts 
  • 1:45-2:45 PM - Gender Diverse Youth with Obesity

    1:45-2:45 PM - Gender Diverse Youth with Obesity

    Speaker

    Dominique Williams, MD

    Description

    There is very little data to help guide clinicians, despite probable similarities in clinical care and lived experiences that affect gender diverse youth with obesity. There is a complex relationship between weight and body habitus, gender identity and expression that could influence engagement in weight management and attrition within structured programs. Based on the high prevalence of victimization and marginalization, treatment goals should consider the negative impact of these social-related complications. Moreover, gender-affirming hormone therapies may worsen obesity, change body composition, or increase cardiovascular risk. Careful attention to barriers to care as well as medical and behavioral comorbidities can inform care to better support clinicians, patients and gender diverse youth with obesity.

    Learning Objectives

    1. Discuss gender identity, gender expression and gender diversity 
    2. Describe how the intersection of obesity and gender identity affects the health of children and adolescents 
    3. Explain how some gender-affirming treatments can worsen obesity, increase the risk or exacerbate weight-related complications 
    4. Use appropriate language when talking with gender diverse youth with obesity 
  • 2:45-3:45 PM - How to Handle "Adulting" in Obesity: Case Studies in Transitional Care

    2:45-3:45 PM - How to Handle "Adulting" in Obesity: Case Studies in Transitional Care

    Speakers

    Eileen Chaves, PhD, Cindi Condos, MSN, FNP

    Jennifer Paisley, MD, FAAP, Dipl. ABOM

    Description

    Most adolescents are not adequately prepared to transition their care from pediatric-oriented to adult-oriented health care.  This is especially concerning given the chronic nature of obesity, access to anti-obesity medication, and utilization of metabolic-bariatric surgery in Adolescent Young Adults (AYA). Moreover, healthcare transitions occur at a time when AYA are also trying to navigate other developmental and emotional milestones.  Using the combined experiences of a pediatric psychologist, Med-Peds obesity medicine specialist, and Pediatric Obesity Coordinator of a Community Health Clinic, this session will inform clinicians and provide insight and specific recommendations on how to approach healthcare transitions in AYA with obesity.

    Learning Objectives

    1. Review the importance of healthcare transitions in the management of Adolescent Young Adult (AYA) with chronic diseases, including overweight and obesity 
    2. Identify developmental challenges and recognize the role of mental health in emotional readiness for AYA transitions 
    3. Describe a stepwise obesity treatment plan that considers disease severity, cultural factors, and other social drivers of health unique to Adolescent Young Adults 
  • 4:00-5:00 PM - Update on Anti-Obesity Medicines

    4:00-5:00 PM - Update on Anti-Obesity Medicines

    Speaker

    Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM

    Description

    This session will review the current state of pharmacology in the treatment of children and adolescents with obesity. 

    Learning Objectives

    1. Review currently approved anti-obesity medications and medication on the horizon for children and adolescents with obesity 
    2. Discuss decision making in using anti-obesity medications in children and adolescents with obesity 
  • 5:00-5:15 PM - Pediatric Q&A

    5:00-5:15 PM - Pediatric Q&A

    Speakers

    Suzanne Cuda, MD, FOMA, FAAP, Dipl. of ABOM

    Eileen Chaves, PhD 

    Learning Objectives

    1. Discuss key takeaways from the Pediatric lectures on Transitional Care and Anti-Obesity Medications 
    2. Ask specific questions about managing obesity within the pediatric population in a Q&A panel with faculty experts 

Register Now